Overexpression of different PKC isoforms has been detected in NSCLC cells and tumour tissues (Clark et al, 2003; Lahn et al, 2006), whereas activation of Akt was associated with significantly worse 5-year survival rate in NSCLC patients (Tang et al, 2006). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.